Literature DB >> 15470363

New insights on the evolution of the SMN1 and SMN2 region: simulation and meta-analysis for allele and haplotype frequency calculations.

Shuji Ogino1, Robert B Wilson, Bert Gold.   

Abstract

Most spinal muscular atrophy patients lack both copies of SMN1. Loss of SMN1 ('0-copy alleles') can occur by gene deletion or SMN1-to-SMN2 gene conversion. Despite worldwide efforts to map the segmental duplications within the SMN region, most assemblies do not correctly delineate these genes. A near pericentromeric location provides impetus for the strong evidence that SMN1 and SMN2 arose from a primate-specific paralogous gene duplication. Here we meta-analyzed our recent laboratory results together with available published data, in order to calculate new mutation rates and allele/haplotype frequencies in this recalcitrant and highly unstable region of the human genome. Based on our tested assumption of compliance with Hardy-Weinberg equilibrium, we conclude that the SMN1 allele frequencies are: '0-copy disease alleles,' 0.013; '1-copy normal alleles,' 0.95; '2-copy normal alleles (ie, two copies of SMN1 on one chromosome),' 0.038; and '1(D) disease alleles (SMN1 with a small intragenic mutation),' 0.00024. The SMN1 haplotype ['(SMN1 copy number)-(SMN2 copy number)'] frequencies are: '0-0,' 0.00048; '0-1,' 0.0086; '0-2,' 0.0042; '1-0,' 0.27; '1-1,' 0.66; '1-2,' 0.015; '2-0,' 0.027; and '2-1,' 0.012. Paternal and maternal de novo mutation rates are 2.1 x 10(-4) and 4.2 x 10(-5), respectively. Our data provide the basis for the most accurate genetic risk calculations, as well as new insights on the evolution of the SMN region, with evidence that nucleotide position 840 (where a transition 840C>T functionally distinguishes SMN2 from SMN1) constitutes a mutation hotspot. Our data also suggest selection of the 1-1 haplotype and the presence of rare chromosomes with three copies of SMN1.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15470363     DOI: 10.1038/sj.ejhg.5201288

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  36 in total

1.  Molecular characterization of SMN copy number derived from carrier screening and from core families with SMA in a Chinese population.

Authors:  Zhu Sheng-Yuan; Fu Xiong; Ya-Jun Chen; Ti-Zhen Yan; Jian Zeng; Liang Li; Ya-Ni Zhang; Wan-Qun Chen; Xin-Hua Bao; Cheng Zhang; Xiang-Min Xu
Journal:  Eur J Hum Genet       Date:  2010-05-05       Impact factor: 4.246

2.  Cost Effectiveness of Nusinersen in the Treatment of Patients with Infantile-Onset and Later-Onset Spinal Muscular Atrophy in Sweden.

Authors:  Santiago Zuluaga-Sanchez; Megan Teynor; Christopher Knight; Robin Thompson; Thomas Lundqvist; Mats Ekelund; Annabelle Forsmark; Adrian D Vickers; Andrew Lloyd
Journal:  Pharmacoeconomics       Date:  2019-06       Impact factor: 4.981

3.  Carrier screening for spinal muscular atrophy in Italian population.

Authors:  Francesco Calì; Giuseppa Ruggeri; Valeria Chiavetta; Carmela Scuderi; Sebastiano Bianca; Chiara Barone; Alda Ragalmuto; Pietro Schinocca; Girolamo Aurelio Vitello; Valentino Romano; Sebastiano Musumeci
Journal:  J Genet       Date:  2014-04       Impact factor: 1.166

Review 4.  Unraveling the genetics of distal hereditary motor neuronopathies.

Authors:  Joy Irobi; Ines Dierick; Albena Jordanova; Kristl G Claeys; Peter De Jonghe; Vincent Timmerman
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

5.  Population carrier screening for spinal muscular atrophy a position statement of the association for molecular pathology.

Authors:  Kasinathan Muralidharan; Robert B Wilson; Shuji Ogino; Narasimhan Nagan; Christine Curtis; Iris Schrijver
Journal:  J Mol Diagn       Date:  2010-12-23       Impact factor: 5.568

6.  Genetic findings of Cypriot spinal muscular atrophy patients.

Authors:  L Theodorou; P Nicolaou; P Koutsou; A Georghiou; V Anastasiadou; G Tanteles; T Kyriakides; E Zamba-Papanicolaou; K Christodoulou
Journal:  Neurol Sci       Date:  2015-05-28       Impact factor: 3.307

7.  Review of Spinal Muscular Atrophy (SMA) for Prenatal and Pediatric Genetic Counselors.

Authors:  Amanda Carré; Candice Empey
Journal:  J Genet Couns       Date:  2015-08-08       Impact factor: 2.537

8.  Notable Carrier Risks for Individuals Having Two Copies of SMN1 in Spinal Muscular Atrophy Families with 2-copy Alleles: Estimation Based on Chinese Meta-analysis Data.

Authors:  Xianda Wei; Hu Tan; Pu Yang; Rui Zhang; Bo Tan; Yue Zhang; Libin Mei; Desheng Liang; Lingqian Wu
Journal:  J Genet Couns       Date:  2016-07-16       Impact factor: 2.537

9.  Differences in SMN1 allele frequencies among ethnic groups within North America.

Authors:  B C Hendrickson; C Donohoe; V R Akmaev; E A Sugarman; P Labrousse; L Boguslavskiy; K Flynn; E M Rohlfs; A Walker; B Allitto; C Sears; T Scholl
Journal:  J Med Genet       Date:  2009-07-21       Impact factor: 6.318

10.  A mitotic recombination map proximal to the APC locus on chromosome 5q and assessment of influences on colorectal cancer risk.

Authors:  Kimberley Howarth; Susanna Ranta; Eitan Winter; Ana Teixeira; Helmut Schaschl; John J Harvey; Andrew Rowan; Angela Jones; Sarah Spain; Susan Clark; Thomas Guenther; Aengus Stewart; Andrew Silver; Ian Tomlinson
Journal:  BMC Med Genet       Date:  2009-06-10       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.